Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07630779
PHASE3

Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol in Non-Diabetic PCOS Patients

Sponsor: Beni-Suef University

View on ClinicalTrials.gov

Summary

This study evaluates the efficacy of alpha-lipoic acid combined with myo-inositol, with or without metformin, in improving menstrual regularity and ovulation in non-diabetic women with polycystic ovary syndrome (PCOS). The study also assesses metabolic, hormonal, and clinical outcomes.

Official title: A Randomized Controlled Trial Evaluating the Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol With or Without Metformin in Non-Diabetic Women With Polycystic Ovary Syndrome

Key Details

Gender

FEMALE

Age Range

21 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2026-03-10

Completion Date

2026-12

Last Updated

2026-06-05

Healthy Volunteers

No

Interventions

DRUG

Myo-inositol

Myo-inositol administered orally at a dose of 2 g twice daily for 6 months.

DIETARY_SUPPLEMENT

Folic Acid

Folic acid administered orally at a dose of 200 micrograms twice daily for 6 months.

DRUG

Alpha Lipoic Acid

Alpha-lipoic acid administered orally at a dose of 600 mg once daily for 6 months.

DRUG

Metfomin

Metformin administered orally starting at 500 mg once daily and titrated over two weeks to a maximum dose of 1500 mg/day (500 mg three times daily), taken after meals for 6 months.

Locations (1)

Faculty of Medicine, Cairo University

Cairo, Cairo Governorate, Egypt